Trellis Bioscience, Inc.
2-B Corporate Drive
South San Francisco, CA 94080
tel 650.616.1100

Directions to Trellis Bioscience

Board Of Directors

James Broderick, MD, joined Morgenthaler Ventures in 1998 and is a partner focused on investments in the life sciences industry. Trained as a physician and an engineer, Jim holds a BS in mechanical engineering from MIT and an MD from the University of Massachusetts. He is a Kauffman Fellow and previously worked as a consultant at Mercer Management Consulting and as a resident at Duke University Medical Center.

Brian Cunningham, Trellis' President and Chief Executive Officer, was President and Chief Operating Officer of Rigel, a clinical stage drug development company. Prior to Rigel he was a partner at Cooley Godward Kronish where he headed the Life Sciences Group, the Health Care Group and Patent Group. Previously, he served as Vice President, Secretary and General Counsel of Genentech, as Associate Corporate Counsel of Monsanto. and as a securities attorney at Winthrop, Stimson, Putnam & Roberts in New York City. He is currently a director of several biotechnology companies.

John Friedman is the founder of Easton Capital Investment Group which manages $200 million in venture capital and private equity funds. Prior, he founded and was Managing General Partner of Security Pacific Capital Investors. He has been Managing Director and Partner at E. M. Warburg, Pincus & Co., was an attorney at Sullivan and Cromwell and coChairs the Cold Spring Harbor Laboratory President's Council. He holds a JD degree from Yale Law School and a BA degree from Yale College.

Markus Goebel, MD, PhD, is Managing Director of the Novartis Venture Fund. Dr. Goebel was Novartis' Head of Pharma Corporate M&A and Nervous System Business Development and Licensing prior to joining the Fund. He has held several positions in R&D, Marketing and Strategy at Roche headquarters before joining Novartis. Dr Goebel received an MD and a PhD from the Ludwig Maximilian's University in Munich and an MBA from Henley Management College.

Lawrence Kauvar, PhD, Founder, Senior Vice President and Chief Scientific Officer. Dr. Kauvar is an entrepreneur and scientist who founded Trellis and was previously the founder and CSO of Telik. He holds 40 US patents for methods, tools and drug compounds and is one of the inventors of CellSpot™, Trellis' core technology. Dr. Kauvar holds a PhD from Yale in Molecular Biophysics and Biochemistry, did his post doctoral studies at Caltech and holds an undergraduate degree from Harvard.

Jerry McMahon, PhD, is Chairman and Chief Executive Officer of Poniard Pharmaceuticals, a clinical stage oncology company. Previously, he was President of SUGEN. Dr McMahon has contributed to more than 100 scientific publications and was a Staff Scientist and Principal Investigator at MIT and Tufts University School of Medicine early in his career. He holds a BS in Biology and a PhD in Biochemistry from Rensselaer Polytechnic Institute.